PMID: 9170147Apr 1, 1997Paper

Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations

Pharmacogenetics
K InoueT Shimada

Abstract

Genomic DNA was isolated from livers of 39 Japanese and 45 Caucasians and the genotypes of CYP2C9 and 2C19 genes were determined with PCR methods using synthetic oligonucleotide primers. Liver microsomes were also prepared from these human samples and activities for tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation were determined. The single base mutation of C416T (Arg144Cys) in CYP2C9 was detected in 22% of Caucasians but not in Japanese samples. Another single base mutation at A1061C (Ile359Leu) in the CYP2C9 gene was found with frequencies of about 8% in both races. We did not detect any individuals who have either homozygous Cys144/Cys144 or Leu359/Leu359 CYP2C9 variant nor both heterozygous Cys144-Ile359 and Arg144-Leu359 CYP2C9 variant in the human samples examined. The CYP2C19m2 genetic polymorphism was found only in Japanese people, while CYP2C19m1 type was determined in both races, with higher incidence in Japanese than in Caucasian population. Immunoblotting analysis of human liver microsomes suggested that CYP2C9 is a major component of the human CYP2C enzyme pool; it accounted for approximately 20% of total P450 in liver microsomes of both human populations. The levels of CYP2C19 protein were dete...Continue Reading

Citations

Oct 31, 2002·Advanced Drug Delivery Reviews·Hong-Guang XieC Michael Stein
Mar 26, 2002·Cancer Letters·Elena García-MartínJosé A G Agúndez
Jul 15, 1998·British Journal of Clinical Pharmacology·J O Miners, D J Birkett
Dec 3, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
Dec 21, 2004·British Journal of Clinical Pharmacology·Carmen MartínezJosé A G Agúndez
Oct 25, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yusuke OkadaHiroshi Yamazaki
Jul 19, 2006·Canadian Journal of Physiology and Pharmacology·Manreet K Chehal, David J Granville
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H G XieC M Stein
Jan 11, 2003·Journal of Clinical Pharmacology·M S ThomsenM Jørgensen
Nov 8, 2001·Journal of Clinical Pharmacology·K VenkatakrishnanD J Greenblatt
Aug 29, 2000·Anesthesia and Analgesia·M SueyasuR Oishi
Sep 18, 2001·Biological & Pharmaceutical Bulletin·T NiwaM Katagiri
Nov 27, 2009·The Journal of Veterinary Medical Science·Yasuhiro UnoHiroshi Yamazaki
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Aug 29, 2001·Clinical Pharmacokinetics·H Takahashi, H Echizen
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Jun 29, 2006·Clinical Pharmacokinetics·Ursula TheuretzbacherHartmut Derendorf
Jul 15, 2005·Pharmacogenomics·Deepak VooraBrian F Gage
Jul 1, 2004·Pharmacogenetics·Dayong SiDafang Zhong
May 2, 2006·Molecular Diagnosis & Therapy·Elena García-MartínJosé A G Agúndez
Sep 3, 2004·Journal of Clinical Pharmacology·Kiman KimHartmut Derendorf
Dec 6, 2005·Diabetes Research and Clinical Practice·Kazuko SuzukiMasahiro Tohkin
Mar 3, 2009·Drug Metabolism and Pharmacokinetics·Akiko YamamotoJunichi Azuma
May 15, 2007·Drug Metabolism and Pharmacokinetics·Katsuhiko TougouJunichi Azuma
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Satoshi YamaoriTetsuya Kamataki
Oct 18, 2014·European Journal of Clinical Pharmacology·Sachiyo HashiKazuo Matsubara
Jun 30, 2016·Expert Review of Anti-infective Therapy·Kathleen M JobCatherine M T Sherwin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.